Pargyline
Generic medicine reference
Not yet clinically reviewed
This entry was migrated from the earlier Pharmapedia app bundle and has not been reviewed by a named clinician on this site. It is provided for educational reference only — verify dosage and safety information against current, authoritative sources and a qualified healthcare professional before any clinical use.
Overview
Pargyline is a selective MAO-B inhibitor which functions by inhibiting the metabolism of catecholamines and tyramine within presynaptic nerve terminal. It is used to treat moderate to severe hypertension.
Indications
Pargyline is primarily indicated in conditions like Hypertension, Parkinson's disease.
Contraindications
Pargyline is contraindicated in conditions like Liver damage, kidney disease.
Side Effects
The severe or irreversible adverse effects of Pargyline, which give rise to further complications include Vertigo, Muscle twitching, Blurred vision. The symptomatic adverse reactions produced by Pargyline are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Vomiting, Fever, Insomnia, Sweating.
Warnings
Take dose at the same time. If unusual allergy reaction occurs consult your doctor or pharmacist. Avoid alcohol or wine with pargyline.
High Risk Groups
Drug should not be given to patients suffering from Kidney dysfunction, and patients suffering from Liver Malfunction. If prescribing authority justifies the benefits of the drug against the possible damages, he/she should reevaluate them and consult the reference material and previous studies.
Adult Dosage
10 to 25 mg (18 (17.5)) 24 hourly oral —
Child Dosage
No child dosage information is recorded for this medicine yet.
Neonatal Dosage
No neonatal dosage information is recorded for this medicine yet.
Drug Interactions
No data regarding the interactions of Pargyline was found.
Storage
No storage information is recorded for this medicine yet.
Available Brands in Pakistan
No brands are recorded for this generic.